Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 66.63%-159.25K | -75.98%92.8K | -208.31%-232.4K | -212.62%-4.86M | -318.13%-4.99M | -300.63%-477.22K | -42.71%386.31K | -80.84%214.57K | 423.42%4.32M | -41.38%2.29M |
| Net income from continuing operations | 118.75%8.24M | -5,180.31%-21.66M | 1,608.65%10.26M | -2,245.18%-47.35M | -747.51%-4.44M | -29,534.21%-43.93M | 17.47%426.26K | -40.45%600.72K | 116.36%2.21M | 128.36%686.23K |
| Operating gains losses | 109.28%197.23K | -2,424.32%-149.16K | -105.20%-260 | -521.36%-128.22K | -755.23%-221.56K | --94.25K | ---5.91K | --5K | --30.43K | --33.81K |
| Depreciation and amortization | 240.34%426.38K | 14.86%146.06K | -6.68%120.01K | 11.83%515.86K | 22.42%134.82K | --125.28K | --127.16K | --128.6K | --461.31K | --110.13K |
| Asset impairment expenditure | ---- | --1.09K | --20.24K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Remuneration paid in stock | 50.45%49.46K | 37.41%61.62K | -22.15%14.86K | -74.37%70.96K | -114.63%-25.85K | --32.88K | --44.85K | --19.09K | --276.82K | --176.67K |
| Unrealized gains and losses of investment securities | ---10.35M | --21.39M | ---10.11M | --4.03M | --4.03M | --0 | --0 | --0 | --0 | ---- |
| Remuneration paid in stock | --0 | --0 | 240.75%45.18K | -14.64%37.26K | --0 | --11.29K | --12.72K | --13.26K | --43.66K | --13.55K |
| Deferred tax | 10,991.52%905.18K | 233.10%199.55K | 150.83%230.04K | 2,368.09%457.2K | 1,406.05%507.25K | --8.16K | ---149.92K | --91.71K | ---20.16K | --33.68K |
| Other non cashItems | -96.49%1.56M | 276.31%188.18K | 262.91%167.39K | 31,655.13%44.99M | 1,241.42%622.7K | 10,316.15%44.58M | 77.69%-106.73K | -173.99%-102.75K | -100.97%-142.58K | -100.88%-54.56K |
| Change In working capital | 101.56%23.47K | 169.07%176.03K | -59.65%-863.82K | -558.05%-7.08M | -448.28%-4.77M | -97.60%-1.51M | -132.27%-254.88K | -464.58%-541.07K | 443.06%1.55M | 1,405.10%1.37M |
| -Change in receivables | -128.70%-316.7K | 41.09%-222.8K | -713.03%-1.07M | 91.29%1.38M | -53.18%484.74K | 454.17%1.1M | ---378.17K | --174.41K | --723.69K | --1.04M |
| -Change in inventory | 623.38%1.55M | 233.09%194.24K | 549.11%174.47K | 213.29%378.74K | 194.19%79.3K | --214.24K | --58.32K | --26.88K | ---334.29K | --26.96K |
| -Change in prepaid assets | -225.83%-141.89K | 224.62%155.92K | -112.14%-243.5K | 378.96%166.31K | 2,575.71%120.3K | 236.56%112.77K | -5.89%48.03K | -285.84%-114.79K | 110.91%34.72K | -93.15%4.5K |
| -Change in payables and accrued expense | 66.13%-995.53K | 313.78%70.12K | 120.89%131.12K | -891.97%-8.88M | -2,243.18%-5.33M | -1,537.90%-2.94M | -97.38%16.95K | -3,131.47%-627.58K | 103,797.87%1.12M | 879.74%248.63K |
| -Change in other working capital | 59.95%-72.2K | -103.79%-21.45K | 695.86%143.26K | ---128.73K | ---532.85K | 15.21%-180.27K | 518.60%566.39K | -72.70%18K | ---- | ---- |
| Interest paid (cash flow from operating activities) | ---1.01M | ---123.26K | ---118.24K | ---192.44K | ---192.44K | --0 | --0 | --0 | --0 | ---- |
| Tax refund paid | -288.34%-209.71K | -149.48%-144.87K | --14.14K | -166.32%-224.33K | ---628.45K | --111.35K | --292.77K | --0 | ---84.23K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 66.63%-159.25K | -75.98%92.8K | -208.31%-232.4K | -212.62%-4.86M | -318.13%-4.99M | -300.63%-477.22K | -42.71%386.31K | -80.84%214.57K | 423.42%4.32M | -41.38%2.29M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,083.80%-28.3M | -470.53%-236.7K | 6.81%-19.16K | 1,110.12%2.86M | 142.61%49.86K | 52.82%2.88M | 95.04%-41.49K | 98.30%-20.56K | 99.76%-283.55K | 87.92%-117.01K |
| Net PPE purchase and sale | -1,094.27%-140.51K | 11.53%-36.7K | 6.81%-19.16K | 91.55%-23.96K | 142.61%49.86K | ---11.77K | ---41.49K | ---20.56K | ---283.55K | ---117.01K |
| Net investment purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | --2.89M | --0 | --646.34K | 371.80%2.27M | 97.32%-32.52K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,083.80%-28.3M | -470.53%-236.7K | 6.81%-19.16K | 1,110.12%2.86M | 142.61%49.86K | 52.82%2.88M | 95.04%-41.49K | 98.30%-20.56K | 99.76%-283.55K | 87.92%-117.01K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,876.77%31.89M | 100.94%936 | 66.72%-201.14K | 162.89%2.59M | 365.89%5.08M | 18.39%-1.79M | -99.37K | -604.4K | -103.53%-4.11M | 36.06%-1.91M |
| Net issuance payments of debt | 63,507.22%41.89M | -99.80%936 | 980.68%798.86K | 33.54%2.86M | 1,742.24%2.25M | -96.74%65.85K | --474.63K | --73.92K | --2.14M | --122.03K |
| Net common stock issuance | ---- | ---- | ---- | --4.34M | ---- | ---- | ---- | ---- | --0 | ---- |
| Net preferred stock issuance | ---6.5M | --0 | ---1M | ---1.5M | ---1.5M | --0 | --0 | --0 | --0 | ---- |
| Net other financing activities | ---- | ---- | ---- | 50.23%-3.11M | 100.00%3 | ---1.86M | ---574K | ---678.32K | -109.04%-6.25M | 31.98%-2.03M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,876.77%31.89M | 100.94%936 | 66.72%-201.14K | 162.89%2.59M | 365.89%5.08M | 18.39%-1.79M | ---99.37K | ---604.4K | -103.53%-4.11M | 36.06%-1.91M |
| Net cash flow | ||||||||||
| Beginning cash position | 32.35%640.41K | 228.58%783.38K | 90.52%1.24M | -10.58%648.81K | 177.65%1.09M | 13.72%483.87K | -59.45%238.41K | -4.63%648.81K | 72,558,600.00%725.59K | -47.03%392.03K |
| Current changes in cash | 467.02%3.43M | -158.25%-142.97K | -10.31%-452.7K | 864.87%587.27K | -42.51%147.62K | 868.02%604.6K | 251.07%245.45K | -344.38%-410.39K | -111.29%-76.78K | 529.41%256.77K |
| End cash Position | 273.79%4.07M | 32.35%640.41K | 228.58%783.38K | 90.52%1.24M | 90.52%1.24M | 177.65%1.09M | 13.72%483.87K | -59.45%238.41K | -4.63%648.81K | -4.63%648.81K |
| Free cash from | 38.70%-299.76K | -83.73%56.1K | -229.67%-251.56K | -222.43%-4.94M | -330.02%-4.99M | -785.62%-488.99K | -48.86%344.82K | -82.67%194K | 389.04%4.03M | -44.38%2.17M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.